nulojix
bristol-myers squibb pharma eeig - belatacept - graft rejection; kidney transplantation - inmunosupresores - nulojix, in combination with corticosteroids and a mycophenolic acid (mpa), is indicated for prophylaxis of graft rejection in adult recipients of a renal transplant.
nulojix
bristol myers squibb argentina s.r.l. - belatacept - polvo liofilizado para inyectable - belatacept 250 mg
nulojix 250 mg 2 vials pols conc perfussió
idefirix
hansa biopharma ab - imlifidase - desensitization, immunologic; kidney transplantation - inmunosupresores - idefirix is indicated for desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor. the use of idefirix should be reserved for patients unlikely to be transplanted under the available kidney allocation system including prioritisation programmes for highly sensitised patients.
myfenax 250 mg capsulas duras efg, 100 capsulas
micofenolato mofetilo teva 500 mg comprimidos recubiertos con pelicula efg, 50 compr
myfenax 500 mg comprimidos recubiertos con pelicula efg 50 comprimidos
cellcept 500 mg
1-roche s.p.a., milan, italia. 2- f. hoffmann-laroche s.a., kaiseraugst, suiza.empacador primario y secundario. - micofenolato de mofetilo - comprimido recubierto - 500 mg
cellcept® 500 mg
delpharm milano s.r.l - micofenolato de mofetilo - comprimido recubierto - 500 mg
micofenolato mofetilo normon 500 mg comprimidos recubiertos con pelicula efg
laboratorios normon s.a. - micofenolato de mofetilo - comprimido recubierto con pelÍcula - 500 mg - micofenolato de mofetilo 500 mg - Ácido micofenólico